An increasing trend was noted also in the number of CD4+ T cells stained for TIM3 or LAG3 in tumor of SR59230A, αPD-L1 treatments and their combination, but they failed to reach statistical significance. This evidence concerns the gene HAVCR2 and neoplasm.